Omnicell (OMCL) Competitors

Omnicell (NASDAQ:OMCL) and HealthStream (NASDAQ:HSTM) are both small-cap health care technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Which has more volatility and risk, OMCL or HSTM?

Omnicell has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Comparatively, HealthStream has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500.

Which has better earnings and valuation, OMCL or HSTM?

HealthStream has lower revenue, but higher earnings than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.11B	1.26	$12.53M	$0.46	65.07
HealthStream	$291.65M	2.90	$20.01M	$0.63	44.02

Do analysts recommend OMCL or HSTM?

Omnicell currently has a consensus target price of $44.83, suggesting a potential upside of 49.79%. HealthStream has a consensus target price of $31.50, suggesting a potential upside of 13.60%. Given Omnicell's higher possible upside, analysts plainly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Does the media prefer OMCL or HSTM?

In the previous week, Omnicell had 2 more articles in the media than HealthStream. MarketBeat recorded 5 mentions for Omnicell and 3 mentions for HealthStream. HealthStream's average media sentiment score of 1.80 beat Omnicell's score of 0.05 indicating that HealthStream is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthStream	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do institutionals and insiders hold more shares of OMCL or HSTM?

97.7% of Omnicell shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 2.5% of Omnicell shares are held by company insiders. Comparatively, 20.6% of HealthStream shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Is OMCL or HSTM more profitable?

HealthStream has a net margin of 6.54% compared to Omnicell's net margin of 1.87%. HealthStream's return on equity of 5.36% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	1.87%	4.60%	2.56%
HealthStream	6.54%	5.36%	3.75%

Summary

HealthStream beats Omnicell on 10 of the 17 factors compared between the two stocks.